Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

141
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
141
Drug Regulation01:25

Drug Regulation

1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Current Trends in Nursing II01:30

Current Trends in Nursing II

1.2K
Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
1.2K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

322
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
322
Standards of Care II01:19

Standards of Care II

635
Nurses bear specific legal responsibilities under several federal statutes, including:
635

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dental devices and antimicrobial resistance: challenges, innovations, and regulatory compliances.

Frontiers in medical technology·2026
Same author

Medical device shelf-life and recalls: navigating healthcare challenges.

Expert review of medical devices·2025
Same author

Software as Medical Devices: requirements and regulatory landscape in the United States.

Expert review of medical devices·2025
Same author

US regulatory compliance for medical combination products: an overview.

Frontiers in medical technology·2024
Same author

Medical Device Sterilization and Reprocessing in the Era of Multidrug-Resistant (MDR) Bacteria: Issues and Regulatory Concepts.

Frontiers in medical technology·2022
Same author

Selective inhibition of Helicobacter pylori methionine aminopeptidase by azaindole hydroxamic acid derivatives: Design, synthesis, in vitro biochemical and structural studies.

Bioorganic chemistry·2021

Related Experiment Video

Updated: Jun 5, 2025

Author Spotlight: Advancing CBCT and Digital Dental Image Integration with AI-Assisted Digitization
05:49

Author Spotlight: Advancing CBCT and Digital Dental Image Integration with AI-Assisted Digitization

Published on: February 23, 2024

769

Navigating regulatory and policy challenges for AI enabled combination devices.

Snigdha Santra1, Preet Kukreja2, Kinshuk Saxena3

  • 1Chugai Pharma, Berkeley, NJ, United States.

Frontiers in Medical Technology
|December 13, 2024
PubMed
Summary
This summary is machine-generated.

Artificial Intelligence (AI) in healthcare combination devices faces regulatory hurdles in the US and EU. New adaptive policy frameworks are needed to balance innovation with patient safety for AI-driven medical technologies.

Keywords:
AI policy frameworksAI regulatory challengesAI regulatory frameworksAI-enabled combination devicesAI-enabled medical devicesFDA AI regulations

More Related Videos

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.4K
Characterization of the Sense of Agency over the Actions of Neural-machine Interface-operated Prostheses
05:21

Characterization of the Sense of Agency over the Actions of Neural-machine Interface-operated Prostheses

Published on: January 7, 2019

7.8K

Related Experiment Videos

Last Updated: Jun 5, 2025

Author Spotlight: Advancing CBCT and Digital Dental Image Integration with AI-Assisted Digitization
05:49

Author Spotlight: Advancing CBCT and Digital Dental Image Integration with AI-Assisted Digitization

Published on: February 23, 2024

769
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.4K
Characterization of the Sense of Agency over the Actions of Neural-machine Interface-operated Prostheses
05:21

Characterization of the Sense of Agency over the Actions of Neural-machine Interface-operated Prostheses

Published on: January 7, 2019

7.8K

Area of Science:

  • Medical Device Regulation
  • Artificial Intelligence in Healthcare
  • Health Technology Assessment

Background:

  • Artificial Intelligence (AI) is transforming healthcare combination devices (CDs).
  • Existing regulatory pathways, like the US FDA's 510(k), struggle with perpetually updating AI.
  • European Union (EU) regulations address AI but face challenges with adaptive algorithms in conformity assessments.

Purpose of the Study:

  • To examine the regulatory landscape for AI-enabled combination devices in the US and EU.
  • To identify obstacles faced by manufacturers and regulators in approving these innovative medical technologies.
  • To propose adaptive policy frameworks for safe and equitable AI adoption in healthcare.

Main Methods:

  • Analysis of US FDA 510(k) pathway limitations for AI devices.
  • Review of EU Medical Device Regulations concerning software and AI.
  • Examination of case studies and recalled devices to understand regulatory navigation challenges.
  • Synthesis of insights to propose adaptive policy recommendations.

Main Results:

  • Regulatory reliance on predicate devices hinders AI innovation, especially for continuously learning algorithms.
  • Current conformity assessments in the EU face difficulties incorporating adaptive AI.
  • Device recalls highlight the critical need for regulatory frameworks addressing AI-specific risks like model degradation and data bias.
  • Manufacturers encounter significant challenges navigating diverse international regulatory requirements.

Conclusions:

  • Adaptive policy frameworks are essential to balance patient safety with the rapid advancement of AI in medical devices.
  • Global standards are recommended to facilitate the safe, effective, and equitable adoption of AI-enabled combination devices.
  • Regulators and policymakers must collaborate to create agile regulatory pathways that accommodate the unique nature of AI in healthcare.